Trial Profile
Sustained prophylactic effect of Xeomin® in adult patients with refractory chronic migraine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 23 Sep 2016 New trial record